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Abstract: The precursor to adenovirus protein VI, pVI, is a multifunctional protein with different roles
early and late in virus infection. Here we focus on two roles late in infection, binding of pVI to DNA
and to the major capsid protein hexon. pVI bound to DNA as a monomer independent of DNA sequence
with an apparent equilibrium dissociation constant, K(d(app.)), of 46 nM. Bound to double-stranded
DNA, one molecule of pVI occluded 8 base pairs. Upon the binding of pVI to DNA, 3 sodium ions were
displaced from the DNA. A ΔG of -4.54 kcal/mol for the nonelectrostatic free energy of binding indicated
that a substantial component of the binding free energy resulted from nonspecific interactions between
pVI and DNA. The proteolytically processed, mature form of pVI, protein VI, also bound to DNA; its
K(d(app.)) was much higher, 307 nM. The binding assays were performed in 1 mM MgCl(2), because
in the absence of magnesium, the binding to pVI or protein VI to DNA was too tight to determine a
K(d(app.)). Three molecules of pVI bound to one molecule of the hexon trimer with an equilibrium
dissociation constant K(d(app.)) of 1.1nM.
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Background: The C terminus of pVI activates the adenovirus proteinase. pVI escorts hexon into the nucleus.
Results: pVI binds tightly to DNA independent of sequence, Kd 46 nM. pVI binds tightly to hexon, Kd 1.1 nM.
Conclusion: DNA binding of pVI is the first step in the activation of adenovirus proteinase.
Significance: This step links pVI, hexon, viral DNA, and the adenovirus proteinase in virion maturation.
The precursor to adenovirus protein VI, pVI, is a multifunc-
tional protein with different roles early and late in virus infec-
tion. Here, we focus on two roles late in infection, binding of
pVI to DNA and to the major capsid protein hexon. pVI bound
to DNA as a monomer independent of DNA sequence with an
apparent equilibrium dissociation constant, Kd(app), of 46 nM.
Bound to double-stranded DNA, one molecule of pVI occluded
8 bp. Upon the binding of pVI to DNA, three sodium ions were
displaced fromtheDNA.AG00 of4.54kcal/mol for thenonelec-
trostatic free energyof binding indicated that a substantial compo-
nent of the binding free energy resulted from nonspecific interac-
tions between pVI and DNA. The proteolytically processed,
mature formof pVI, proteinVI, also bound toDNA; itsKd(app) was
much higher, 307 nM. The binding assays were performed in 1mM
MgCl2 because in the absence ofmagnesium, the binding to pVI or
proteinVI toDNAwas too tight to determine aKd(app). Threemol-
ecules of pVI bound to one molecule of the hexon trimer with an
equilibrium dissociation constantKd(app) of 1.1 nM.
Many viral proteins contain several different domains that
function at different steps during a virus infection. This is cer-
tainly true of the precursor to protein VI, pVI,4 and of its pro-
teolytically processed product, protein VI, of adenovirus that
are involved in steps both early and late in infection. Early in
infection, virus particles engage in a stepwise disassembly pro-
gramcoordinated in time and space during entry into cells lead-
ing to the delivery of the viral genome into the nucleus for
replication (1–4). Protein VI is involved in endosome disrup-
tion (5, 6). Late in infection, new virus particles are assembled
and rendered infectious. pVI interacts withDNA to activate the
adenovirus proteinase (AVP) (41) and with hexon, the major
structural proteins of adenovirus, to escort hexon into the
nucleus (7, 8).
Adenoviruses (9) are nonenveloped, icosahedral eukaryotic
viruses that infect a wide range of species. In the subgroup C of
human adenoviruses, Ad2 or Ad5 are the best characterized.
They have an36-kb double-stranded DNA genome (10). The
Ad2/Ad5 particle is about 90 nm in diameter and consists of an
outer capsid surrounding an inner nucleoprotein core. Hexon,
penton base, and fiber are the major structural proteins in the
outer capsid. Hexon is the major protein of the facets of the
icosahedral virus. The size of the hexonmolecule can vary with
the serotype; the largest, from Ad2, has 967 amino acids (9).
There are 720 copies of hexon present as 240 homotrimers per
virion. One face of the hexon trimer in the capsid is exposed to
the core of the virus and hence the viral DNA. Protein VI is
thought to lie within the internal cavity of each hexon trimer
(11–16). There are 360 copies of proteinVI, which contains 206
amino acids. Protein VI has been shown to bind to DNA inde-
pendent of nucleotide sequence (17).
Initiation of an Ad2/Ad5 infection occurs when the capsid
binds to high affinity receptors on the cell surface (3, 18–20),
and the virus particle is internalized via clathrin-mediated
endocytosis (21–23). After internalization, protein VI, the pro-
teolytically processed form of pVI, is rapidly exposed (3, 24).
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Protein VI mediates endosome disruption, so the partially
uncoated capsid can enter the cytoplasm (5).
Late in adenovirus infection, the genes for pVI, AVP, and
hexon are transcribed from the L3 transcription region on the
viral DNA (25). AVP is synthesized as an inactive enzyme (26,
27). Thenuclear transport of hexon ismediated by pVI as hexon
does not have a nuclear localization signal. pVI contains two
nuclear export signals and two nuclear localization signals (7,
28, 29). pVIc,5 the last 11 amino acids of pVI, contains an
nuclear localization signal. It has been shown that the nuclear
import of hexon in cultured cells occurs via pVI, which shuttles
between the nucleus and the cytoplasm and appears to provide
an adaptor for hexon import (7).
Adenovirus virions are assembled in part from precursor
proteins. Of the 12major virion proteins, six are precursor pro-
teins in the young virion, an assembly intermediate. The penul-
timate step before the appearance of infectious virus is the acti-
vation of the AVP, a 23-kDa cysteine proteinase (30, 31)
followed by the processing of the virion precursor proteins.
AVP is activated by two cofactors, pVIc (GVQSLKRRRCF) (26,
27), the 11-amino acid peptide from the C terminus of pVI (26).
In pVI, anAVP consensus cleavage site, IVGL2G, immediately
precedes pVIc and is cleaved by AVP between Leu and Gly to
release pVIc (41). The other cofactor, the viral DNA genome
(26, 32, 33), consists of 35,937 bp of linear DNA in the case of
Ad2. The viral cofactors dramatically stimulate the macro-
scopic kinetic constants for substrate hydrolysis (32, 34, 35).
The relative kcat/Km of AVP is enhanced 110-fold in the pres-
ence of DNA and 1130-fold in the presence of pVIc.When both
cofactors are bound to AVP, the kcat/Km increases synergisti-
cally, by 16,000-fold. AVP, pVI, pVIc, and AVP-pVIc com-
plexes (where AVP-pVIc is a noncovalent or covalently linked
heterodimer of AVP and pVIc) bind tightly to DNAwith nano-
molar equilibrium dissociation constants; binding is independ-
ent of nucleic acid sequence (see Table 1) (26, 32, 33, 36, 41).
How does pVI activate AVP, and in particular, is DNA
involved in that process? If so, what is the nature of its role?
Here, we clone and express the genes for pVI and its mature,
processed form, protein VI, purifying both proteins from Esch-
erichia coli. We show that pVI does indeed bind to DNA inde-
pendent of DNA sequence.We quantitatively characterize that
interaction, and, in the next paper in this series (41), we show
that novel modes of interaction with DNA are crucial to the
activation of AVP by pVI. Here, we also characterize, quantita-
tively, the interaction of pVI and hexon, providing a molecular
basis for the previously observed pVI dependence of hexon
import to the nucleus (7).
EXPERIMENTAL PROCEDURES
Materials—The 11-amino acid peptide pVIc (GVQSLKRRRCF)
was purchased fromNew England Peptide Inc. (Gardner, MA).
The 5-fluorescein-labeled 33-merDNA, 36-merDNA, 60-mer
DNA, and the strands complementary to theseDNAswere pur-
chased from Invitrogen, as was streptavidin Alexa Fluor 546.
Annealing of complementaryDNAswas done as described pre-
viously (35). The 1500-mer dsDNA was obtained by sonicating
CupriavidusmetalliduransCH34 genomicDNA. n-Dodecyl--
D-maltopyranoside (DDM) was purchased from Anatrace
(Maumee, OH). Cy3Bmonomaleimidewas purchased fromGE
Healthcare. 5-Iodoacetamidofluorescein was purchased from
Pierce. The complex (pVIc-biotin)streptavidin was synthe-
sized as described.6 The fluorogenic substrates (Leu-Arg-Gly-
Gly-NH)2-rhodamine and (Cbz-Leu-Arg-Gly-Gly-NH)2-rho-
damine were synthesized and purified as described previously
(26, 37). AVP and the AVPmutant C122A7 were purified using
published procedures (26, 34). Coomassie Blue-stained or sil-
ver-stained protein gels were scanned on a flatbed scanner, and
the bands were quantitated with the GE Healthcare
ImageQuant software. Buffer A was 20 mM Hepes (pH 7.0),
0.025% (w/v) DDM, and 0.1 mM DTT. Buffer B was 20 mM
Tris-HCl (pH 8.0), 0.025% DDM, and 0.1 mM DTT. pVIc was
labeled with Cy3B as described previously.6
Cloning of pVI and VI—Expression plasmids containing the
pVI orVI open reading frameswere acquired in two steps. First,
PCR products were synthesized using Ad2 genomic DNA
(Sigma) as template. The pVI ORF PCR product was inserted
between a BsaI site and a blunt end. The VI ORF PCR product
was inserted betweenNdeI and BamHI sites. Primers were pur-
chased from Invitrogen. Sequences of the primers were as fol-
lows: for pVI, the forward primer, pVIf, was 5-AAGGGTCTC
ACA TGG AAG ACA TCA ACT TTG CGT CTC TG-3 and
incorporated a BsaI site (underlined). The reverse primer, pVIr,
was 5-GAA GCA TCG TCG GCG CTT CAG GGA TTG-3
with a blunt end. For VI, the forward primer, VIf, was 5-ATT
CCA TAT GGC CTT CAG CTG GGG CTC GCT G-3 and
incorporated anNdeI site (underlined), and the reverse primer,
VIr, 5-GGTTGGATCCTTACAGACCCACGATGCTGT
TCAG-3 incorporated aBamHI site (underlined). For efficient
VI expression, VIf contained an initiator Met codon just prior
to the Ala codon at the site of the N-terminal consensus cleav-
age site of the adenovirus proteinase, and VIr contained a stop
codon after the Leu codon at the consensus cleavage site of the
adenovirus proteinase near theC terminus of pVI. After restric-
tion, protein VI was ligated into a pET13a vector, whereas pVI
was ligated into a pREX-S31 vector. The resultant plasmids
were subcloned into Top10 cells. Sequence verification was
performed to ensure the presence of the correct reading frame
and absence of mutations. pVI- and VI-expressing bacteria
were obtained by transformation of E. coli BL21 (DE3) RIL
Codon Plus cells for both constructs.
Expression of pVI and VI—The genes for pVI and VI were
expressed overnight at 37 °C by autoinduction in ZYM-5052
medium (38). The bacterial cells were collected by centrifuga-
tion at 20,000  g for 20 min and stored at 20 °C. Protein
expression was confirmed by SDS-PAGE on bacterial lysates.
Purification of pVI and VI—Frozen E. coli cell paste (5 g)
was suspended in 50 ml of lysis buffer containing 50 mM Tris-
5 The following designations are used in this study: AVP-pVIc, noncovalent or
covalently linked heterodimer of AVP and pVIc; pVIc, 11-amino acid cofac-
tor (GVQSLKRRRCF) originating from the C-terminus of virion precursor
protein pVI.
6 P. C. Blainey, V. Graziano, W. J. McGrath, G. Luo, X. S. Xie, and W. F. Mangel,
submitted.
7 W. J. McGrath and W. F. Mangel, unpublished observations.
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HCl (pH 7.5), 100mMNaCl, 5mMEDTA, 1%DDM, 1mMDTT,
1mMPMSF, 1mM benzamidine-HCl, and 1 tablet of Complete,
EDTA-free protease inhibitor mixture (Roche Applied Sci-
ence). Lysozyme to 0.01 mg/ml was added, and the cell suspen-
sion was mixed by end-over-end rotation at room temperature
for 60min. The cell lysate was then sonicated intermittently for
5 min on ice. Nucleic acids were further digested by the addi-
tion of 2.5 units of Benzonase. The suspension was clarified by
centrifugation at 10 °C in an SS-34 rotor for 30min at 30,000
g. The supernatant was diluted 2-fold to lower the salt concen-
tration and with a peristaltic pump loaded onto a low pressure
40-ml Macro-Prep high S cation-exchange cartridge. The car-
tridge had previously been equilibrated in 25mMMES (pH 6.5),
0.1 mM EDTA, 1 mM DTT, and 0.05% DDM. The flow rate was
3 ml/min. Proteins were eluted using 15 column volumes of a
linear salt gradient between 0 and 1MNaCl. Protein elutionwas
monitored at 280 nm, and 1-min fractions were collected. Frac-
tions containing pVI were identified by SDS-PAGE on a 15%
polyacrylamide gel and pooled; protein in the pool was concen-
trated in an Amicon Ultra 10,000 molecular weight cut-off
membrane. The pVI was then diluted 3-fold with 25 mM MES
(pH 6.5), 0.1 mM EDTA, 1 mM DTT, and 0.05% DDM and
loaded onto a 15-ml POROS 20 HS cation-exchange column at
a flow rate of 2 ml/min. Proteins were eluted in a 20 column
volume linear gradient from 0 to 500 mM NaCl. Fractions con-
taining pVI were identified by SDS-PAGE and pooled; the pVI
was concentrated to about 1 ml. pVI was further purified by
size-exclusion chromatography on a HiLoad 16/60 Superdex
200 prep grade column (Amersham Biosciences). The column
was equilibrated with 25 mM Tris-HCl (pH 7.5), 150 mM NaCl,
0.1 mM EDTA, 1 mM DTT, and 0.05% DDM. The flow rate was
0.75 ml/min; 1 ml of sample was injected. The protein elution
profile was obtained from the optical density at 280 nm, and
2-min fractions were collected. Fractions with pVI greater than
98%purewere identified by SDS-PAGEandpooled. The pooled
fractions were diluted 5-fold with 25 mMMES (pH 6.5), 0.025%
DDM, 0.1 mM EDTA, and 1 mM DTT and then loaded onto a
small cation-exchange column. The columnwaswashed exten-
sively, and the pVI was eluted with 0.8 MNaCl, 25mMMES (pH
6.5), 0.1mMEDTA, 0.025%DDM, and 1mMDTT.This step not
only led to pVI being more concentrated but also ensured that
the concentration of DDM in the buffer was 0.025%. Fractions
with pure pVI were then dialyzed against storage buffer, which
contained 12.5mMMES (pH 6.5), 0.025%DDM, 25mMNaCl, 0.1
mM EDTA, and 1 mMDTT. The concentration of pVI was deter-
minedusingacalculatedmolarextinctioncoefficientof30480M1
cm1. Aliquots of pVIwere frozen in liquid nitrogen and stored at
80 °C. Protein VI was purified by the same procedure.
Equilibrium Dissociation Constants—Equilibrium dissocia-
tion constants from anisotropy experiments and enzymatic
activity assays were calculated as described previously (32).
Purification of Hexon—Hexon was purified by modifications
of the procedures of Burnett (39). CsCl top fractions from a
crude extract of Ad2-infected HeLaS3 cells were thawed and
dialyzed overnight against 1 liter of 10 mM Tris-HCl, pH 8, at
4 °C. After dialysis, the solution was centrifuged for 30 min at
4 °C at 6700  g to remove any insoluble material. All further
chromatography steps were carried out at 21 °C. The clarified
solution was loaded onto a 15-ml Fractogel EMDTMAEHicap
(M) strong anion-exchange column at a flow rate of 2 ml/min.
The column was washed extensively with 10 mM Bis-Tris-pro-
pane, pH 7, and bound proteins were eluted with a linear salt
gradient from 0 mM to 500 mM NaCl. Hexon-enriched fractions
were identifiedbySDS-PAGEandeluted fromthe columnaround
0.4 M NaCl. The fractions were pooled (20 ml), diluted 1:2 with
10 mM Bis-Tris-propane, pH 7, and loaded onto a 15-ml POROS
20 HQ strong anion-exchange column, previously equilibrated in
the same buffer. Hexon was eluted from the column with a linear
salt gradient as described above except that it eluted at 0.65 M
NaCl. Pure hexon fractionswere identified by SDS-PAGE, pooled,
and dialyzed against 1 liter of storage buffer consisting of 10 mM
sodium phosphate, pH 7, 0.02% sodium azide. Hexonwas quanti-
tated spectrophotometrically using a calculated extinction coeffi-
cient of 156430 M1cm1 and stored on ice.
Steady-state Fluorescence Intensity and Anisotropy Mea-
surements—Steady-state fluorescence intensity and anisotropy
measurements were performed on an ISS PC-1 spectrofluo-
rometer with 19-A lamp current, 564-nm excitation wave-
length, and 580-nm emission filter. The G factor for anisotropy
experiments wasmeasured before the beginning of each exper-
iment. 1 ml of Cy3B labeled pVI was placed inside a quartz
cuvette in buffer containing 20 mMHepes, pH 7, 150 mMNaCl.
After each addition of hexon, the liquid was mixed by pipetting
the solution up and down four times and allowed to reach equilib-
riumfor2minbeforeopening the shutters to acquiredata. Steady-
state fluorescence intensity data were acquired in the absence of
polarizers to increase the fluorescence signal.
Photobleaching Data Analysis—Fluorescence images of an iso-
lated and immobilized singlemolecule of (pVIc-biotin)streptavidin-
Alexa Fluor 546 complex or Cy3B-pVI were processed as fol-
lows. For each image frame, the average fluorescence peak
intensity was calculated by summing all neighboring pixels with
intensity values above a certain threshold and then dividing by the
number of neighbors.All remainingpixels in that framewere con-
sideredbackgroundnoise andwereprocessed in a similarmanner.
The net peak intensity was obtained by subtracting the average
background noise from the average peak intensity.
RESULTS
Cloning, Expression, and Purification of pVI and VI—The
T7-based system (38) was employed for the cloning and expres-
sion of the adenovirus precursor protein pVI and its proteolyti-
cally processed, mature form, protein VI, as described under
“Experimental Procedures.” Purification of pVI and VI was
accomplished by cation-exchange and size-exclusion chroma-
tography. The proteins were about 99% pure, as assessed by
SDS-PAGE (see Fig. 6B) and byMALDI-TOF analysis. pVI and
VI required a detergent to keep them in solution. Below a con-
centration of DDM of 0.0125%, the proteins were insoluble, as
determined by dynamic light scattering.
Binding of pVI and Protein VI to DNA—The interactions of
pVI and VI with DNA have not been previously characterized.
We used fluorescence anisotropy to measure the Kd(app) for the
binding of pVI to dsDNA. Aliquots of pVI were added to a
solution of 33-mer dsDNA in which one of the strands was
labeled at its 5-end with fluorescein, and the fluorescence ani-
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sotropywas determined as described under “Experimental Pro-
cedures.” The data are presented in Fig. 1 in the form of a Bjer-
rum plot. The Kd(app) was 46  1.6 nM (Table 1). A similar
experiment was performed with protein VI (Fig. 1). The Kd(app)
was much higher, 307 38 nM (Table 1). These binding assays
were done in 1 mM MgCl2 because in the absence of magne-
sium, the binding to DNA was too tight to determine a Kd(app).
Stoichiometry of Binding of pVI to DNA—How many mole-
cules of pVI bind to one molecule of 60-mer dsDNA? The stoi-
chiometry of binding of pVI to DNA was ascertained using
fluorescence anisotropy under tight binding conditions, condi-
tions in which the concentration of one of the ligands was at
least 10-fold greater than its Kd(app). Increasing amounts of pVI
were added to a constant amount of 5-fluorescein-labeled
60-mer dsDNA, and the change in anisotropy upon each addi-
tion was measured. The concentration of fluorescein-labeled
dsDNA was much higher than the Kd(app). Under these tight
binding conditions, at pVI concentrations below saturation of
DNA, all pVI present will be bound to DNA; above saturation,
no added pVI will be able to bind to DNA. As shown in Fig. 2A,
as the concentration of pVI was increased, the anisotropy
increased linearly. Once saturation was reached, there was no
further increase in anisotropy as additional pVI was added. The
data points could be characterized by two straight lines using a
linear fitting routine. The intersection point of the two lines is
the minimal concentration of pVI required to saturate the
DNA.Because this occurred at a concentration of pVI of 110 nM
and the concentration of 60-mer dsDNA was 13.7 nM, the stoi-
chiometry of binding of pVI to 60-mer dsDNA was 8:1, eight
molecules of pVI per molecule of 60-mer dsDNA. Similar
experiments were performedwith 33-mer, 18-mer, and 12-mer
dsDNA.8 When the maximal number of molecules of pVI
bound to one DNA molecule is plotted versus the DNA length
in base pairs, a straight line through the origin was observed
(Fig. 2B). This implied that one molecule of pVI occluded 8 bp
of DNA. Most important, these data also indicated that pVI
bound to DNA independent of the sequence of the DNA.
Number of Ion Pairs in the Binding of pVI to DNA—To fur-
ther characterize the DNA binding interface, we determined
the number of ion pairs involved in the binding of pVI to DNA.
At different ionic strengths, 12-mer dsDNA labeled at one of its
5 ends with fluorescein was incubated with increasing concen-
trations of pVI. The equilibrium dissociation constants (Kd)
were determined by fluorescence anisotropy (Fig. 3A). The log
(Kd) was plotted versus log[NaCl] (Fig. 3B). The following equa-





whereM is themonovalent counterion concentration,m is the
number of ion pairs formed, and  is the fraction of a counterion
associated, in the thermodynamic sense, with each phosphate of
DNA in solution. For dsDNA,  is 0.88 (40). The number of ion
pairs formed upon binding of a pVI to 12-mer dsDNAwas 2.9.
Nonelectrostatic Free Energy of Binding of pVI to dsDNA—
The nonelectrostatic change in free energy, 
G00, upon binding
of pVI to DNA was also calculated. The line in Fig. 3B was




0  RTlnKo (Eq. 2)
where Ko is KA in 1 M Na. The 
G00 (1 M Na) was4.0 kcal/
mol. By correction for three lysine-like ion pairs, which have a

G00 (1 MNa) of 3 0.18 kcal, the nonelectrostatic free energy
of binding was calculated to be4.54 kcal/mol. The Kd values
from Fig. 3A were 60, 144, 327, 452, and 1036 nM in 0.02, 0.03,
0.04, 0.05, and 0.06MNaCl, respectively. By extrapolation of the
line (Fig. 3B), the Kd in 1 M NaCl was 1154 M.
pVI Slides Along DNA as a Monomer—The oligomeric state
of pVI was difficult to determine because pVI requires deter-
gent to be soluble. For this reason, we resorted to an indirect
assay, a single-molecule photobleaching assay, to see whether
pVI is a monomer or an oligomer.
In the image series of pVI sliding along DNA, occasionally a
labeled molecule of pVI would be seen to stick irreversibly to
the glass surface of the coverslip (41). If the exciting light
remained on, eventually the fluorophore would bleach. Such an
event, with labeled pVI from a pVI preparation that had a ratio
of Cy3B label to protein of 0.9, is shown in Fig. 4A. Before the
Cy3B-labeled molecule of pVI stuck to a spot on the glass, the
fluorescence intensity at that spot was zero. Upon pVI sticking
to the glass, the fluorescence intensity abruptly increased. The
fluorescence intensity remained constant for about 0.5 s and
then abruptly decreased to zero. Abrupt, one-step photo
bleaching of a molecule irreversibly bound to the glass slide is
characteristic of the visualization of a protein molecule labeled
with a single dye molecule. Were the fluorescence from more
than one dye molecule on a protein or from more than one
labeled protein, upon bleaching, the fluorescence would have8 V. Graziano and W. F. Mangel, unpublished observations.
FIGURE 1. Binding of pVI and VI to DNA. Equilibrium dissociation constants
were calculated. Aliquots of pVI or VI were added to buffer Bwith 1mMMgCl2
containing 10 nM fluorescein-labeled 33-mer dsDNA, and the steady-state
anisotropy after each additionwasmeasured at 21 °C. Thedata are presented
in the form of a Bjerrum plot and yielded apparent equilibrium dissociation
constants of 46  1.6 nM for pVI (open circles) and 307  38 nM for VI (open
squares). Data points are averages of three replicates  S.D. The solid lines
were obtained by inverse variance weighted nonlinear regression fit of a 1:1
ligand-receptor binding model to the data.
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diminished in multiple steps as several colocalized dye mole-
cules would not likely bleach simultaneously. One-step photo
bleaching was observed in 30 out of 30 bleaching events.
Because in the same microscope field the fluorescence intensi-
ties of themolecules that were sliding onDNAwere the same as
those that stuck to the glass whose bleaching was observed, we
conclude that under these conditions, pVI was sliding alongDNA
as a monomer. In a control experiment (Fig. 4B), a (pVIc-
biotin)streptavidin complex6 with two molecules of Alexa Fluor
546per streptavidinmolecule irreversibly stuck to theglass surface
during a sliding assay. Although its fluorescence intensity rose
abruptly upon binding to the glass surface, bleaching occurred in
two steps, as predicted from the labeling quantization.
pVI Binding to Hexon—The interactions of purified pVI to
the hexon trimer have not been quantitatively characterized.
We used fluorescence quenching to measure the Kd(app) for the
binding of pVI to hexon. Aliquots of hexon were added to a
solution of pVI labeled with Cy3B, and the intensity of fluores-
cence was determined as described under “Experimental Pro-
cedures.” The data are presented in Fig. 5A. The Kd(app) was
1.1 0.16 nM (Table 1).
Stoichiometry of Binding of pVI to Hexon—Howmany mole-
cules of pVI bind to one molecule of hexon? The stoichiometry
of binding of pVI to hexon was ascertained using fluorescence
anisotropy under tight binding conditions. In this case, the con-
centration of Cy3B-labeled pVI, 20 nM, was more than 10-fold
greater than its Kd(app) for binding to hexon. Experimentally,
increasing amounts of hexon were added to a constant amount
of Cy3b-labed pVI, and the change in anisotropy upon each
addition was measured. As shown in Fig. 5B, as the concentra-
tion of hexon was increased, the anisotropy increased linearly.
Once saturation was reached, there was no further increase in
anisotropy as additional hexon was added. The data points
could be characterized by two straight lines using a linear fitting
routine. The intersection point of the two lines is the minimal
concentration of hexon required to saturate pVI. Because this
occurred at a concentration of hexon of 25 nM, and the concen-
tration of pVI was 20 nM, the stoichiometry of binding of pVI to
hexon monomer was 1:1.
The Form of Hexon to Which pVI Binds—In solution and in
the crystal structure, hexon is a trimer. Our data showed that
one molecule of pVI binds to one molecule of hexon. Does this
mean that three molecules of pVI bind to one molecule of
hexon trimer? Fig. 6 shows a chromatogram of hexon and
hexonpVI complexes from size-exclusion chromatography
analysis. Although the estimated molecular weight of hexon is
consistent with that of a trimer, an estimate of the molecular
weight of the hexonpVI complex is problematic because we do
not know the overall shape of the complex. Given the large shift
in retention time of the hexonpVI complex, it is likely that pVI
induces a rather large conformational change in the hexon
structure.
DISCUSSION
The gene for pVI was cloned and expressed in E. coli, and the
resultant protein was purified and characterized. pVI was puri-
fied to homogeneity. pVI had not been purified before, and
some of the previous experiments with pVI and proteinVIwere
done with proteins that had at one time been denatured (17).
The binding of pVI to DNAwas independent of DNA sequence
and was very tight. The Kd(app) for the binding of pVI to DNA
was 46 nM. However, the binding assays had to be done in 1mM
MgCl2 because in the absence of magnesium, the binding to
DNA was too tight to determine a Kd(app). A similar problem
arose in characterizing the binding of pVI to hexon. At 10 nM,
we observed tight binding; this implied that the Kd(app) was
probably much lower. The binding of pVI to DNA was medi-
ated by ionic contacts as the binding was sensitive to ionic
strength. On the other hand, the binding of pVI to hexon can
occur even in the presence of 1 M NaCl. However, that binding
appeared to be due to hydrophobic interactions as that interac-
tion was sensitive to detergents.8
pVI is a monomer at nM concentrations. Previously, we had
shown that pVI slides along DNA via one-dimensional diffu-
sion (41); its one-dimensional diffusion constant is 1.45  106
bp/s. In the sliding assays, we observed photo bleaching of pVI.
Because the drop in fluorescence due to bleaching occurred in a
single step, we concluded that pVI was sliding as a monomer.
Both pVI and VI required a detergent to be soluble. As judged
by dynamic light scattering, the minimum amount of DDM
required for pVI to remain in solution was 0.0125%.
pVI may bind to DNA mostly through its pVIc moiety. The
Kd(app) for the binding of pVI to DNA was 46 nM. AVP-pVIc
complexes also bind tightly to DNA. TheKd(app) is 4.6 nM. Both
protein VI and AVP bind less tightly to DNA. Their Kd(app)
values are almost 10-fold higher, 307 and 63 nM, respectively.
Secondly, the number of base pairs covered while bound to
DNA is similar; pVI covers 8 bp, and AVP-pVIc complexes
TABLE 1
Binding to DNA and sliding along DNAs via one-dimensional diffusion of adenovirus proteins





nM bp (bp)2/s 106
pVI 27,014 33-mer dsDNA 46 1.6 8 1.45 0.13c
pVI 27,014 Hexon 1.1 0.16
VI 22,118 33-mer dsDNA 307 38
pVIcd 1350 12-mer dsDNA 264 25 26.0 1.8
AVPe 23087 12-mer dsDNA 63 5.8
AVP-pVIc 24435 36-mer dsDNA 4.6 2.2e 6e 21.0 1.9f
a The error in Kd(app) denotes the standard error obtained from inverse variance weighted nonlinear regression fit of the data.
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cover 6 bp (32). In contrast, the virion precursor protein pIIIa
covers 33 bp.8 Third, some thermodynamics parameters of pVI
binding to DNA are similar to those of AVP-pVIc complexes
binding to DNA (32), namely the number of ion pairs formed
and the nonelectrostatic free energy of binding.
The nonsequence-specific interaction between pVI and DNA
exhibited a substantial dependence on monovalent sodium ion
concentration. This dependence reflects the electrostatic com-
ponent of the binding reaction (40). The electrostatic compo-
nent originates from the formation of ion pairs between posi-
tively charged groups on pVI and negatively charged phosphate
groups on DNA. After binding occurs, there is a concomitant
release of counterions from the DNA and, possibly, from pVI.
From an analysis of the equilibrium association constants for
the binding of pVI to 12-mer dsDNA as a function of the Na
concentration, an accurate estimate of the number of ion pairs
involved in the interaction was obtained. Three ion pairs were
involved in binding to 12-mer dsDNA. For comparison, two ion
pairs of AVP-pVIc complexes are involved in its interaction
with DNA (32).
FIGURE2.StoichiometryofbindingofpVI toDNA.A, stoichiometry of bind-
ing. Aliquots of pVI were added to solutions of buffer B containing 13.7 nM
60-bp DNA labeled at one 5 end with fluorescein. After each addition, the
steady-state anisotropy was measured. The solid lines are linear fits to the
data. The point of intersection of the straight lines, the dashed vertical line, indi-
cates that a minimum of 110 nM pVI was required to saturate 13.7 nM 60-bp
dsDNA, a stoichiometry of binding of 8:1. The experiment was repeated with
33-mer, 18-mer, and 12-mer dsDNA.8 Data points are averages of four repli-
cates S.D. B, the number of base pairs occluded upon binding of pVI to DNA.
The data from the experiments in A were used to plot the ratio of pVI to DNA
versusDNA length (bp). The average number of bp per pVI binding sitewas 8.
FIGURE 3. Thermodynamic parameters in the binding of pVI to DNA.
A, number of ionpairs involved inbindingof pVI toDNA. Binding isothermsof
pVI binding to 10 nM fluorescein-labeled 12-mer dsDNA in buffer B are shown
as a function of the NaCl concentration (black, 0.02 M; red, 0.03 M; blue, 0.04 M;
green, 0.05 M; and pink, 0.06 M). Binding was measured by changes in fluores-
cence anisotropy as the pVI concentrationwas increased, as described under
“Experimental Procedures.” Data points are averages of four replicates S.D.
The solid curves are inverse weighted nonlinear regression fit of the data to a
1:1 bindingmodel. B, changes in nonelectrostatic free energy upon the bind-
ingofpVI toDNA. The logof theequilibriumdissociation constants calculated
fromthedata inAareplotted versuslog [NaCl]. The error barsdenote theS.E.
in the Kd value obtained from the nonlinear regression fit of the data in A. The
solid line is a weighted linear regression fit of the data.
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There also seems to be a substantial, favorable nonelectro-
static component of the binding interaction. Upon extrapola-
tion to 1MNa of the line in Fig. 3B, the
G00 was4.0 kcal/mol
for pVI. The 
G00 is 4.2 kcal/mol for AVP-pVIc complexes
(32). Correction for three lysine-like ion pairs makes the non-
electrostatic free energy of binding4.5 kcal/mol for pVI. This
indicates that a substantial component of the binding free
energy under physiological conditions results from nonspecific
interactions between pVI and base or sugar residues on the
DNA and that the dominant factor driving the nonspecific
interaction between pVI and DNA is the entropic contribution
from the release of counterions.
Although it had been known that pVI binds to hexon (17),
pVI had not, heretofore, been purified so that its interaction
with hexon could be quantitatively characterized. In the virion,
hexon appears as a homotrimer and is the major component of
the capsid, forming the faces of the icosahedral surface. The
arrangement of the hexon trimers alters at the vertices of the
capsid, where the peripentonal hexons interact with the penton
base. Our data on the binding of pVI to hexon showed that one
molecule of pVI binds to one hexonmolecule. Perhaps after pVI
escorts hexon into the nucleus, some pVI dissociates from
hexon and binds to the viral DNA because the local viral DNA
FIGURE 4. Oligomeric state of pVI determined by single molecule photo
bleaching. A, in an image series (1.2 kW/cm2, 0.00352 s/frame) of a sliding
assay of pVI molecules labeled with Cy3B at an efficiency of 0.9 Cy3B mole-
cules/pVI molecule, one of the molecules irreversibly stuck to a spot on the
surface of the glass coverslip; the fluorescence intensity at that spot was
recorded as a function of time. Bleaching occurred in one step. a.u., arbitrary
units. B, an experiment similar to that in A except that a molecule of a (pVIc-
biotin)streptavidin complex labeled with two molecules of Alexa Fluor 5468
stuck to a spot on the surface of the glass coverslip. The bleaching of the
(pVIc-biotin)streptavidin complex occurred in two steps. The red line is the
average intensity in that time range.
FIGURE 5. Equilibrium binding and tight binding of pVI to hexon.
A, change in fluorescence intensitywhen 1 nMCy3B-pVI is titratedwith hexon
in 20 mM Hepes, 150 mM NaCl, pH 7. Both pVI and hexon concentrations are
reported as monomer concentrations. The dissociation constant (Kd) was
determined by inverse variance weighted nonlinear regression fit of the
steady-state fluorescence intensity data to a single site receptor-ligand bind-
ing model. The Kd is 1.1  0.16 nM. Data points are averages of five repli-
cates  S.D. B, binding data for pVI-hexon interaction under tight binding
condition. Changes in fluorescence anisotropy are observed when 20 nM of
Cy3B-pVI is titrated with increasing amounts of hexon (monomer concentra-
tion) in buffer containing 20mMHepes, 150mMNaCl, pH 7. The stoichiometry
of binding is determined by the intersection of the two linear regression lines
from the first seven and last six data points. Data points are averages of four
replicates S.D.
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concentration is so high. After virion assembly, pVI then acti-
vates AVP on the DNA, and the resultant protein VI, given its
10-fold higher Kd(app), dissociates from the DNA and binds to
its final position in infectious virus.
There are multiple functions at the two ends of pVI. pVI is
processed by AVP first at its N terminus and then at its C ter-
minus (41). Upon processing by AVP, some of these functions
may be terminated and others derepressed. The N terminus of
pVI has membrane lytic activity (5). Initially, AVP cleaves off a
peptide from pVI that contains amino acids 1–33. This may
expose a predicted amphipathic -helix (residues 36–53) that
has been shown to be essential for membrane lytic activity in
protein VI. Alternatively, the membrane lytic activity at the N
terminus of pVI may be buried within hexon and exposed only
after pVI dissociates from hexon. The last 11 amino acids of
pVI, amino acids 239–250, facilitate binding to DNA. Their
removal is reflected in the almost 10-fold higher Kd(app) for
protein VI relative to that of pVI. Also, the removed C-terminal
peptide, pVIc, activates AVP (26, 27) and enables it to slide
along DNA via one-dimensional diffusion to process the virion
precursor proteins (42). Premature exposure of the membrane
lytic activity before virion assembly or premature activation of
AVP may be harmful to the infected cell, inhibit virion assem-
bly, and possibly abort the infection. For example, if pVIc is
added to cells along with adenovirus, the yield of infectious
virus is down by more than 99% (35).
pVI and its processed form protein VI are remarkable pro-
teins because they exhibit many quite different functions at
various stages of an adenovirus infection. Two of those func-
tions, binding to DNA and sliding along DNA, require nonspe-
cific binding to DNA, which we have characterized here. Also,
pVI binds tightly to hexon so that they can enter the nucleus
together. Itwill be interesting to see howduring virion assembly
pVI dissociates from being tightly bound to hexon and binds
tightly to the viral DNA, a prerequisite to the activation of AVP.
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